Despite a massive 107-times subscription during its September 2026 IPO, Rays of Belief is trading below its issue price of ₹239. The for-profit social enterprise, which recently reported a turnaround to profit, faces market scrutiny over the long-term scalability and financial sustainability of its neuro-developmental therapy business model.
Rays of Belief Ltd, the operator of the Mom’s Belief brand, made headlines when it listed on the stock exchanges on September 8, 2026. The initial public offering (IPO) of ₹125 crore attracted immense interest, with investors subscribing over 107 times. However, the initial market excitement has cooled, and the stock is currently trading in the range of ₹226 to ₹230, which is below its IPO issue price of ₹239.
The company operates in a unique niche, providing therapy for neuro-developmental disorders like autism. While it positions itself as a for-profit social enterprise, its financial results show a recent improvement. For the first quarter of the 2027 fiscal year, the company reported a net profit of ₹2.79 crore. This is a significant turnaround from the net loss of ₹53.7 lakh reported in the same quarter of the previous year. This profit was supported by a surge in revenue as the company aggressively expanded its network. As of March 2026, the firm operated 136 centers across 57 cities in India and had established 3 centers in the United States.
Despite the profit turnaround, investors appear cautious about the long-term earnings potential. One of the main challenges for this business model is the operational complexity involved in hiring and retaining specialized clinical staff. Unlike standard retail or manufacturing businesses, the quality of service here depends heavily on expert therapists. Expanding too quickly carries the risk of rising costs, which can put pressure on profit margins if the company cannot maintain its service quality and occupancy levels at new centers.
Another factor influencing investor sentiment is the cost of care for parents. Families dealing with neuro-developmental disorders often face a severe financial burden, as many general health insurance policies do not provide adequate coverage for these specific therapies. Rays of Belief has attempted to address this by introducing proprietary insurance plans, which covered 429 children as of March 2026. However, market experts and some observers remain watchful, questioning whether a for-profit model can balance the need for corporate growth with the affordability required by the families they serve.
The current stock performance suggests that the market is waiting for more evidence that the company can grow its scale without seeing its margins drop due to high staffing costs or intense competition. Moving forward, shareholders will likely monitor the company’s ability to manage its expanding center network, the stability of its clinical staff, and its ability to prove that its profit growth is sustainable over the long term.